Eko Named to the 2020 CB Insights Digital Health 150 -- List of Most Innovative Digital Health Startups

August 13, 2020

Eko recognized for achievements in AI-powered analysis of cardiopulmonary disease

NEW YORK, August 13, 2020 -- CB Insights today named Eko to its second annual  Digital Health 150 ranking, which showcases the 150 most promising private digital health companies in the world. 


The 2020 Digital Health 150 cohort highlights startups that are reimagining the lines of the traditional healthcare experience across 12 categories, from Virtual Care Delivery and Clinical Trials, to Drug Discovery and Specialty Care. Countries represented this year include Canada, China, Israel, France, the United Kingdom, and the United States, among others. 

“This year’s Digital Health 150 is our most global ever, covering the best private healthcare companies from 17 countries. Beyond geographic diversity, these companies are innovating across the entire healthcare value chain, spanning technologies that benefit pharma & biotech companies, to payers, hospitals, insurers, and more,” said CB Insights CEO Anand Sanwal. “Last year’s Digital Health 150 winners saw numerous exits and went on to raise nearly $5 billion in investor financing after being recognized. We look forward to seeing the success of this year's class of the best in digital health."

We are honored to be recognized alongside this outstanding cohort of companies working to elevate the quality and accessibility of healthcare. Eko’s mission to improve cardiopulmonary disease screening and monitoring is made stronger by the digital health ecosystem featured on this year’s CB Insights Digital Health 150 list. - Jason Bellet, Co-Founder & Chief Customer Officer.


Through an evidence-based approach, the CB Insights research team selected the Digital Health 150 from hundreds of applications based on several factors including patent activity, investor quality, news sentiment analysis, proprietary Mosaic scores, market potential, partnerships, competitive landscape, team strength, and tech novelty. The Mosaic Score, based on CB Insights’ algorithm, measures the overall health and growth potential of private companies to help predict a company’s momentum. 

Quick facts on the 2020 Digital Health 150:

  • The 2020 Digital Health 150 startups have raised over $20B in funding across 600+ deals from 900+ unique investors.
  • The list includes 12 unicorns (companies that have reached a valuation of $1B+) focused on a diverse range of digital health solutions, including telehealth, insurance, and robotic surgical systems.
  • Many have formed partnerships with key industry players like the American Heart Association, Cigna, and Mount Sinai Health System.

See all Digital Health 150 Companies →

About CB Insights

At CB Insights, we believe the most complex strategic business questions are best answered with facts.  We are a machine intelligence company that synthesizes, analyzes and visualizes millions of documents to give our clients fast, fact-based insights. Serving the majority of the Fortune 100, we give companies the power to make better decisions, take control of their own future, and capitalize on change.


Contact:

Keith Swiader, Manager - PR & Communications
keith.swiader@cbinsights.com
917-214-1028


About Eko

Eko is elevating the way clinicians detect and monitor cardiac and respiratory disease by bringing together advanced sensors, patient and provider software, and AI-powered analysis. Its FDA cleared platform is used by tens of thousands of clinicians treating millions of patients around the world, in-person, and through telehealth. The company is headquartered in Oakland, California and privately-held, with investments from ARTIS Ventures, NTT Venture Capital, DigiTx Ventures, Mayo Clinic, Sutter Health and others.

 

For more information, visit www.ekohealth.com.

More from our blog